Abstract
BackgroundDemyelinating syndrome (DS) secondary to Systemic Lupus Erythematosus (SLE) is rare (<1%) but represents a challenging condition for both patients and clinicians.ObjectivesTo describe the features of DS secondary to SLE...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
